Literature DB >> 17688947

A novel shRNA vector that enables rapid selection and identification of knockdown cells.

Akira Nagasaki1, Masamitsu Kanada, Taro Q P Uyeda.   

Abstract

Small interference RNA (siRNA) is a powerful tool for disrupting expression of specific genes in a variety of cells. We have developed a vector, piMARK, which mediates expression of both small hairpin RNA (shRNA) and the blasticidin resistance (Bsr) protein fused with enhanced green fluorescent protein (EGFP), enabling rapid selection and identification of knockdown cells. Using this vector, we targeted Ect2, a gene encoding a guanine nucleotide exchange factor for several small GTPases, in human cell lines. Incubation in the presence of 10 microg/ml blasticidin S rapidly killed untransfected cells, so that after 24 h >90% of surviving HeLa S3 cells emitted green fluorescence and >70% were binucleate as a result of the frequent failure of cell division. The GFP-Bsr fluorescence enabled easy identification of individual knockdown cells under a fluorescence microscope, which in turn enabled unambiguous assessment of the morphological consequences of silencing Ect2. Moreover, because untransfected cells rapidly died and detached from the substrate, they were easily removed by simply rinsing the culture dishes. It thus should be possible to analyze the biochemical consequences of gene silencing en masse in the absence of a background of untransfected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688947     DOI: 10.1016/j.plasmid.2007.01.006

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  2 in total

1.  Novel functions of Ect2 in polar lamellipodia formation and polarity maintenance during "contractile ring-independent" cytokinesis in adherent cells.

Authors:  Masamitsu Kanada; Akira Nagasaki; Taro Q P Uyeda
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

2.  Dasatinib induces autophagic cell death in human ovarian cancer.

Authors:  Xiao-Feng Le; Weiqun Mao; Zhen Lu; Bing Z Carter; Robert C Bast
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.